{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:58:15Z","timestamp":1769122695128,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cpcardiol.2024.102483","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:44:17Z","timestamp":1708688657000},"page":"102483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The role of ICDs in patients with sarcoidosis\u2013A comprehensive review"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7039-4269","authenticated-orcid":false,"given":"Sebastian","family":"Mactaggart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0001","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102483_bib0002","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"issue":"37","key":"10.1016\/j.cpcardiol.2024.102483_bib0003","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr\u00f6m","year":"2019","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102483_bib0004","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11886-019-1238-1","article-title":"Cardiac sarcoidosis","volume":"21","author":"Mankad","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","article-title":"Cardiac sarcoidosis","volume":"157","author":"Kim","year":"2009","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0006","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac sarcoidosis: the impact of age and implanted devices on survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.cpcardiol.2024.102483_bib0007","first-page":"e210","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102483_bib0008","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"40","key":"10.1016\/j.cpcardiol.2024.102483_bib0009","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102483_bib0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-8703(97)70070-X","article-title":"Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block","volume":"134","author":"Yoshida","year":"1997","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102483_bib0011","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102483_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"13","key":"10.1016\/j.cpcardiol.2024.102483_bib0013","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.121.058120","article-title":"Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator","volume":"146","author":"Nordenswan","year":"2022","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102483_bib0014","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102483_bib0015","doi-asserted-by":"crossref","first-page":"272","DOI":"10.5603\/CJ.a2018.0104","article-title":"Cardiac sarcoidosis and ventricular arrhythmias. A rare association of a rare disease. A retrospective cohort study from the National Inpatient Sample and current evidence for management","volume":"27","author":"Salama","year":"2020","journal-title":"Cardiol J"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102483_bib0016","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102483_bib0017","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","volume":"37","author":"Nery","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0018","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0019","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1749-6632.1986.tb18531.x","article-title":"The prognosis of sarcoid heart disease in the United Kingdom","volume":"465","author":"Fleming","year":"1986","journal-title":"Ann NY Acad Sci"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102483_bib0020","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102483_bib0021","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","article-title":"Cardiac sarcoidosis: a retrospective study of 41 cases","volume":"83","author":"Chapelon-Abric","year":"2004","journal-title":"Medicine"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102483_bib0022","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurjhf\/hfr099","article-title":"Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study","volume":"13","author":"Patel","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102483_bib0023","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac Involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0024","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102483_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007488","article-title":"Assessment of the 2017 AHA\/ACC\/HRS Guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis","volume":"12","author":"Kazmirczak","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102483_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007844","article-title":"Hospitalization rates, prevalence of cardiovascular manifestations, and outcomes associated with sarcoidosis in the United States","volume":"7","author":"Patel","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ahj.2021.12.011","article-title":"Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy","volume":"246","author":"Higgins","year":"2022","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0028","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102483_bib0029","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","article-title":"A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis","volume":"41","author":"Okura","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102483_bib0031","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cardfail.2023.03.022","article-title":"Sex and race differences in cardiac sarcoidosis presentation, treatment and outcomes","volume":"29","author":"Duvall","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2021.10.150","article-title":"Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria","volume":"345","author":"Takaya","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0033","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12872-022-02639-0","article-title":"Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience","volume":"22","author":"Bobbio","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102483_bib0034","article-title":"Cardiac sarcoidosis and giant cell myocarditis: actually, 2 ends of the same disease?","volume":"10","author":"Birnie","year":"2021","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102483_bib0035","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.hrthm.2022.02.027","article-title":"Sex-related differences in the prognosis of patients with cardiac sarcoidosis treated with cardiac resynchronization therapy","volume":"19","author":"Nakasuka","year":"2022","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102483_bib0036","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial Difference in Sarcoidosis Mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102483_bib0037","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jjcc.2012.08.002","article-title":"Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis","volume":"60","author":"Shafee","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0038","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjcard.2020.04.025","article-title":"Risk of adverse cardiovascular events in cardiac sarcoidosis independent of left ventricular function","volume":"127","author":"Rosenthal","year":"2020","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102483_bib0039","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102483_bib0040","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1253\/circj.CJ-14-1217","article-title":"Association between basal thinning of interventricular septum and adverse long-term clinical outcomes in patients with cardiac sarcoidosis","volume":"79","author":"Nagano","year":"2015","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102483_bib0041","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.resinv.2022.02.001","article-title":"Basal interventricular septum thinning and long-term left ventricular function in patients with sarcoidosis","volume":"60","author":"Tanizawa","year":"2022","journal-title":"Respir Investig"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102483_bib0042","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/life13081653","article-title":"The role of echocardiography in the contemporary diagnosis and prognosis of cardiac sarcoidosis: a comprehensive review","volume":"13","author":"Okafor","year":"2023","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102483_bib0043","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjcard.2018.09.044","article-title":"Effect of cardiac resynchronization therapy on left ventricular remodeling in patients with cardiac sarcoidosis","volume":"123","author":"Patel","year":"2019","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102483_bib0044","first-page":"824","article-title":"Cardiac resynchronization therapy for patients with cardiac sarcoidosis","volume":"19","author":"Sairaku","year":"2017","journal-title":"EP Eur"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102483_bib0045","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/jce.15631","article-title":"Cardiac resynchronization therapy response in cardiac sarcoidosis","volume":"33","author":"Shabtaie","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102483_bib0046","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jce.13119","article-title":"Outcome of patients with cardiac sarcoidosis who received cardiac resynchronization therapy: comparison with dilated cardiomyopathy patients","volume":"28","author":"Yufu","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0047","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102483_bib0048","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/pace.14722","article-title":"Prognostic value of late-gadolinium enhancement on cardiac magnetic resonance in patients with cardiac sarcoidosis","volume":"46","author":"Al-Sadawi","year":"2023","journal-title":"Pacing Clin Electrophysiol"},{"issue":"15","key":"10.1016\/j.cpcardiol.2024.102483_bib0049","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0050","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ijcard.2016.07.233","article-title":"High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis","volume":"222","author":"Agoston-Coldea","year":"2016","journal-title":"Int J Cardiol"},{"issue":"20","key":"10.1016\/j.cpcardiol.2024.102483_bib0051","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102483_bib0052","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0053","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2020.11.044","article-title":"Risk and predictors of sudden death in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"328","author":"Franke","year":"2021","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0054","first-page":"1574","article-title":"Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: meta-analysis and systematic review","volume":"30","author":"Adhaduk","year":"2023","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102483_bib0055","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/jce.15484","article-title":"Predictors of appropriate implantable cardiac defibrillator therapy in cardiac sarcoidosis","volume":"33","author":"Mathijssen","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102483_bib0056","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jcmg.2019.12.011","article-title":"Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis","volume":"13","author":"Velangi","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0057","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ehf2.12166","article-title":"Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance","volume":"4","author":"Smedema","year":"2017","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0058","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.11-3214","article-title":"Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications","volume":"143","author":"Viles-Gonzalez","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0059","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.106.4.1021","article-title":"Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis","volume":"106","author":"Suzuki","year":"1994","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-8703(89)90670-4","article-title":"Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases","volume":"117","author":"Bay\u00e9s de Luna","year":"1989","journal-title":"Am Heart J"},{"issue":"17","key":"10.1016\/j.cpcardiol.2024.102483_bib0061","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM200010263431701","article-title":"Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos","volume":"343","author":"Valenzuela","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0062","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0735-1097(91)90750-4","article-title":"Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device","volume":"18","author":"Winters","year":"1991","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102483_bib0063","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1253\/circj.CJ-17-0701","article-title":"Trends in hospitalizations for cardiac sarcoidosis in the United States, 2005\u20132011","volume":"81","author":"Guo","year":"2017","journal-title":"Circ J"},{"issue":"17","key":"10.1016\/j.cpcardiol.2024.102483_bib0064","doi-asserted-by":"crossref","first-page":"330","DOI":"10.21037\/atm.2018.07.33","article-title":"The burden of cardiac arrhythmias in sarcoidosis: a population-based inpatient analysis","volume":"6","author":"Desai","year":"2018","journal-title":"Ann Transl Med"},{"issue":"18","key":"10.1016\/j.cpcardiol.2024.102483_bib0065","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/heartjnl-2022-322243","article-title":"Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis","volume":"109","author":"Iso","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0066","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijcard.2017.03.033","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"241","author":"Bravo","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0067","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0068","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjcard.2020.08.007","article-title":"Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"134","author":"Gowani","year":"2020","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102483_bib0069","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102483_bib0070","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102483_bib0071","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102483_bib0072","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102483_bib0073","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/jce.14689","article-title":"Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: insights from implantable cardioverter-defibrillator diagnostics","volume":"31","author":"Medor","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102483_bib0074","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102483_bib0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10840-015-9978-3","article-title":"Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator","volume":"43","author":"Kron","year":"2015","journal-title":"J Interv Card Electrophysiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102483_bib0076","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jce.12302","article-title":"Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator","volume":"25","author":"Mohsen","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102483_bib0077","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102483_bib0078","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.amjcard.2005.03.059","article-title":"Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis","volume":"96","author":"Aizer","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0079","article-title":"Electrophysiology study for risk stratification in patients with cardiac sarcoidosis and abnormal cardiac imaging","volume":"23","author":"Okada","year":"2019","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1590\/S0066-782X2011005000041","article-title":"Cardiac electrophysiological assessment in patients with sarcoidosis","volume":"96","author":"Curimbaba","year":"2011","journal-title":"Arq Bras Cardiol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102483_bib0081","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/jce.14058","article-title":"Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function","volume":"30","author":"Zipse","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cpcardiol.2024.102483_bib0082","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2021.11.061","article-title":"The role of electrophysiology study in risk stratification of cardiac sarcoidosis patients: meta-analyses and systemic review","volume":"349","author":"Adhaduk","year":"2022","journal-title":"Int J Cardiol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:40:02Z","timestamp":1758940802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0146280624001221"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102483","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of ICDs in patients with sarcoidosis\u2013A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102483"}}